In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders? (original) (raw)

The paper investigates the neuroprotective strategies in glaucoma in relation to experiences from other neurodegenerative disorders. It examines the loss of retinal ganglion cells and its correlation with visual field defects, highlighting the complexity of the disease and the role of various risk factors. The discussion extends to the mechanisms of action via NMDA receptor modulation, emphasizing the potential for pharmacological intervention to mitigate cell death and progressive damage in glaucomatous conditions.